Showing
1 - 3
results of
3
Skip to content
VuFind
Log in
Library Catalogue Plus
Library
Subject guides
Databases
Referencing
Catalogue
Articles Plus
Keyword
Title
Author
Subject
Find
Advanced Search
Search Results - Meng, Zhiqiang, Prof
Search Results - Meng, Zhiqiang, Prof
Showing
1 - 3
results of
3
Refine Results
Sort
Relevance
Date Descending
Author
Title
1
Loading…
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
by
Ren, Zhenggang, Prof
,
Xu, Jianming, Prof
,
Bai, Yuxian, Prof
,
Xu, Aibing, Prof
,
Cang, Shundong, Prof
,
Du, Chengyou, Prof
,
Li, Qiu, Prof
,
Lu, Yinying, Prof
,
Chen, Yajin, Prof
,
Guo, Yabing, Prof
,
Chen, Zhendong, Prof
,
Liu, Baorui, Prof
,
Jia, Weidong, Prof
,
Wu, Jian, Prof
,
Wang, Junye, Prof
,
Shao, Guoliang, Prof
,
Zhang, Bixiang, Prof
,
Shan, Yunfeng, Prof
,
Meng, Zhiqiang, Prof
,
Wu, Jianbing, Prof
,
Gu, Shanzhi, Prof
,
Yang, Wei, Prof
,
Liu, Chao, Prof
,
Shi, Xuetao, Prof
,
Gao, Zhenyuan, Prof
,
Yin, Tao, Prof
,
Cui, Jiuwei, Prof
,
Huang, Ming, Prof
,
Xing, Baocai, Prof
,
Mao, Yilei, Prof
,
Teng, Gaojun, Prof
,
Qin, Yanru, Prof
,
Wang, Jinhai, Prof
,
Xia, Feng, Prof
,
Yin, Guowen, Prof
,
Yang, Yong, MD
,
Chen, Mingxia, MD
,
Wang, Yan, MD
,
Zhou, Hui, MD
,
Fan, Jia, Prof
Published in
The lancet oncology
Get full text
Items that this one cites
Items that cite this one
Article
Save to List
Saved in:
2
Loading…
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
by
Qin, Shukui, Prof
,
Ren, Zhenggang, Prof
,
Meng, Zhiqiang, Prof
,
Chen, Zhendong, Prof
,
Chai, Xiaoli, Prof
,
Xiong, Jianping, Prof
,
Bai, Yuxian, Prof
,
Yang, Lin, Prof
,
Zhu, Hong, MD
,
Fang, Weijia, Prof
,
Lin, Xiaoyan, Prof
,
Chen, Xiaoming, MD
,
Li, Enxiao, Prof
,
Wang, Linna, MD
,
Chen, Chunxia, MSc
,
Zou, Jianjun, MD
Published in
The lancet oncology
Get full text
Items that this one cites
Items that cite this one
Article
Save to List
Saved in:
3
Loading…
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
by
Llovet, Josep M, Prof
,
Kudo, Masatoshi, Prof
,
Merle, Philippe, Prof
,
Meyer, Tim, Prof
,
Qin, Shukui, Prof
,
Ikeda, Masafumi, MD
,
Xu, Ruocai, MD
,
Edeline, Julien, MD
,
Ryoo, Baek-Yeol, MD
,
Ren, Zhenggang, Prof
,
Masi, Gianluca, MD
,
Kwiatkowski, Mariusz, MD
,
Lim, Ho Yeong, MD
,
Kim, Jee Hyun, Prof
,
Breder, Valeriy, MD
,
Kumada, Hiromitsu, MD
,
Cheng, Ann-Lii, MD
,
Galle, Peter R, MD
,
Kaneko, Shuichi, MD
,
Wang, Anran, PhD
,
Mody, Kalgi, MD
,
Dutcus, Corina, MD
,
Dubrovsky, Leonid, MD
,
Siegel, Abby B, MD
,
Finn, Richard S, MD
Published in
The lancet oncology
Get full text
Items that this one cites
Items that cite this one
Article
Save to List
Saved in:
Search Tools:
RSS Feed
Email Search
Save Search
Back
Refine Results
Page will reload when a filter is selected or excluded.
Limit To
Peer Reviewed
3 results
3
Full Text
3 results
3
Format
Articles
3 results
3
Journal Title
The Lancet Oncology
3 results
3
Subjects
Hematology, Oncology, And Palliative Medicine
3 results
3
Hepatocellular Carcinoma
3 results
3
Life Sciences & Biomedicine
3 results
3
Liver Cancer
3 results
3
Monoclonal Antibodies
3 results
3
Oncology
3 results
3
Science & Technology
3 results
3
Targeted Cancer Therapy
3 results
3
Aspartate Aminotransferase
2 results
2
Biological Products
2 results
2
Cancer Therapies
2 results
2
Carcinoma, Hepatocellular - Drug Therapy
2 results
2
Clinical Trials
2 results
2
Consent
2 results
2
Fda Approval
2 results
2
Female
2 results
2
Hemorrhage
2 results
2
Humans
2 results
2
Immunotherapy
2 results
2
Inhibitor Drugs
2 results
2
Year of Publication
From:
To:
Source
Sciencedirect Journals
3 results
3
Sciencedirect Freedom Collection
3 results
3